Wells Fargo’s Teva Pharmaceuticals TEVA Stock Holding History

Wells Fargo’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-175,000	Closed	-$3.15M	–	7190
2024 Q3	$3.15M	Buy	+175,000	New	+$3.06M	﹤0.01%	2720
2022 Q3	–	Sell	-250,000	Closed	-$1.88M	–	7354
2022 Q2	$1.88M	Buy	+250,000	New	+$2.18M	﹤0.01%	2853
2021 Q4	–	Sell	-400,000	Closed	-$3.9M	–	7797
2021 Q3	$3.9M	Buy	+400,000	New	+$3.75M	﹤0.01%	3077
2021 Q2	–	Sell	-43,200	Closed	-$499K	–	7431
2021 Q1	$499K	Sell	43,200 -206,800	-83%	-$2.37M	﹤0.01%	4685
2020 Q4	$59K	Buy	+250,000	New	+$2.4M	﹤0.01%	5545
2020 Q2	–	Sell	-450,000	Closed	-$210K	–	6814
2020 Q1	$210K	Sell	450,000 -275,000	-38%	-$2.82M	﹤0.01%	4652
2019 Q4	$501K	Buy	+725,000	New	+$6.47M	﹤0.01%	4366
2017 Q4	–	Sell	-116,000	Closed	-$2K	–	6519
2017 Q3	$2K	Sell	116,000 -37,500	-24%	-$844K	﹤0.01%	6170
2017 Q2	$130K	Buy	153,500 +20,000	+15%	+$619K	﹤0.01%	5043
2017 Q1	$100K	Sell	133,500 -75,000	-36%	-$2.56M	﹤0.01%	5199
2016 Q4	$278K	Buy	208,500 +108,500	+109%	+$4.33M	﹤0.01%	4583
2016 Q3	$2K	Sell	100,000 -39,800	-28%	-$2.08M	﹤0.01%	6053
2016 Q2	$33K	Buy	+139,800	New	+$7.44M	﹤0.01%	5340
2014 Q3	–	Sell	-100,000	Closed	-$5.24M	–	6341
2014 Q2	$5.24M	Hold	100,000	–	–	﹤0.01%	2292
2014 Q1	$925K	Buy	+100,000	New	+$4.62M	﹤0.01%	3554

Other funds holding TEVA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wells Fargo's TEVA Position: Q1 2026 in Review

Wells Fargo reduced its Teva Pharmaceuticals (TEVA) stake by 25% in Q1 2026, selling an estimated $5.17M and leaving 487,018 shares worth $14.7M. The position accounts for ﹤0.01% of the portfolio, ranked #1735.

Wells Fargo first reported a position in TEVA in Q2 2013 and has held it in 52 quarters since. The position peaked at $183M in Q1 2015. 651 funds tracked by Wall St. Rank hold TEVA as of Q1 2026.

Wells Fargo held 487,018 shares of Teva Pharmaceuticals worth $14.7M as of Q1 2026.
Wells Fargo sold 160,835 Teva Pharmaceuticals shares in Q1 2026, an estimated $5.17M.
Teva Pharmaceuticals made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #1735 holding.
Wells Fargo first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
Wells Fargo's Teva Pharmaceuticals position peaked at $183M in Q1 2015.
651 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.